| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105156A1 Non-virulent porphyromonas gingivalis mutant |
| 06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
| 06/13/2001 | EP1105141A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 06/13/2001 | EP1105105A1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 06/13/2001 | EP1105097A2 Targeted vesicular constructs for cytoprotection and treatment of h.pylori infections |
| 06/13/2001 | EP1105002A2 Carbohydrates mixture |
| 06/13/2001 | EP1104999A1 Protein component for dietetic food |
| 06/13/2001 | EP0944571B1 Asiatic acid derivatives having modified a-ring |
| 06/13/2001 | EP0687174B1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| 06/13/2001 | EP0686034B1 Bisacodyl dosage form |
| 06/13/2001 | DE19958985A1 Oligosaccharidmischung Oligosaccharide |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299348A SPLA inhibitor compounds for treatment of disease |
| 06/13/2001 | CN1299291A Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 06/13/2001 | CN1298934A Process for preparing tonic wine |
| 06/13/2001 | CN1298737A Medical pill for treating hepattis and its preparing process |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1298705A Chinese medicine for treating hepatitis B and its preparing process |
| 06/13/2001 | CN1298659A Process for preparing flavouring to prevent hepatitis B |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1066962C Teeth nuring agent |
| 06/13/2001 | CN1066956C Traditional Chinese medicine for treating gastro-duodenal ulcer and gastrorrhagia |
| 06/13/2001 | CN1066951C Patent traditional Chinese medicine for treating tuberculosis and hepatosis |
| 06/13/2001 | CN1066949C Patented traditional Chinese medicine capsule for treating gastric duodenal ulcer and gastritis |
| 06/13/2001 | CN1066948C Medicine for treating gastric ulcer and duodenal ulcer |
| 06/13/2001 | CN1066941C Oral liquid for treat babies abdoninal pain due to stagnation of qi, gastric cavity flatulence and postoperative abdominal distention |
| 06/13/2001 | CN1066939C Pharmaceutical composition contg. thiazolidine denvative and prepn. process-thereof |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245813 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245801 Branched alkyl pyrrolidine-3-carboxylic acids |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245749 Nucleosides with anti-hepatitis B virus activity |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245326 Health supplement |
| 06/12/2001 | US6244871 Bioactive glass compositions and methods of treatment using bioactive glass |
| 06/12/2001 | CA2014544C Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040263A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040262A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040197A1 Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001015553B1 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO1999052548A9 Conjugate vaccines for the prevention of dental caries |
| 06/07/2001 | US20010002998 Over-coated chewing gum formulations including tableted center |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | CA2390349A1 Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104653A1 Composition for animals containing a methyl salicylate |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104438A2 Novel anti-diabetic peptides |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104417A1 Improved omeprazole process and compositions thereof |
| 06/06/2001 | EP1104413A2 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104408A2 Drug targeting |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
| 06/06/2001 | EP1104288A1 Orally disintegrable tablet forming a viscous slurry |
| 06/06/2001 | EP1104281A1 Incorporation of exogenous lactic bacteria into the oral microflora |
| 06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | CN1298411A Caspase-8 interacting proteins |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298391A 1-[(1-substituted-4-piperidinyl) methyl]-4-piperidine derivatives, process for producing the same medicinal compositions containing the same and intermediate of these compounds |
| 06/06/2001 | CN1298306A Treatment of i (C. Difficile) toxin B associated conditions |
| 06/06/2001 | CN1297890A Matrine and inorganic salt of matrinidine and their preparation |